As the Executive Director of the Brawerman Nursing Institute at Cedars Sinai, Dr. Minissian has worked diligently to reduce nurse sensitive indicators, increase research and publications among Cedars-Sinai nursing, restructured the resuscitation program for clinical staff to reduce costs and improve employee satisfaction. Dr. Minissian is working to ensure all nursing fellowship programs receive PTAP accreditation by the American Nurses Credentialing Center. Most Recently, Cedars-Sinai was recognized as the 2020 NICHE and ABIM Foundation Choosing Wisely® Trailblazer award. This award recognizes the clinical team for improving care for older adults in one of the clinical areas identified by the American Academy of Nursing’s Choosing Wisely® recommendations.
As a prevention scientist, Dr. Minissian has a strong interest in protecting healthcare workers during the Covid-19 pandemic. Most recently, her team published in Nurse Leader and she implemented her research methods to registered nurses (RNs), “The Coronavirus Risk Associations and Longitudinal Evaluation- Nurses Surveillance Study (CORALE-NS)” to address the overarching hypothesis that pre-clinical increases in inflammatory proteins in RNs working under repeated exposure to Covid-19 positive patients, place these workers at increased risk for severe disease prior to them testing positive for Covid-19.
Dr. Minissian is the Director of the Postpartum Heart Health Program, Registry and Biorepository which has been designed to help identify, risk stratify and treat women who experience adverse pregnancy outcomes. Her National Institutes of Health (NIH) funded studies focus on women with adverse pregnancy outcomes.
Dr. Minissian completed her biological research PhD at the University of California, Los Angeles (UCLA) School of Nursing, was a UCLA Dean’s Scholar Fellow and a UCLA Regents Scholar. She is published in over 40 peer reviewed journals.